JFLLIFEPharmaceuticals
JFL LIFE SCIENCES — Profit & Loss Statement
₹8.55
-4.32%
JFL LIFE SCIENCES Profit & Loss Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax Rate For Calcs | 0.13 | 0.24 | 0.26 | 0.27 |
| Normalized EBITDA | 4.99 Cr | 5.47 Cr | 6.22 Cr | 2.25 Cr |
| Total Unusual Items | 0.00 | — | — | — |
| Total Unusual Items Excluding Goodwill | 0.00 | — | — | — |
| Net Income From Continuing Operation Net Minority Interest | 3.31 Cr | 2.81 Cr | 2.81 Cr | 0.54 Cr |
| Reconciled Depreciation | 0.44 Cr | 0.43 Cr | 0.37 Cr | 0.28 Cr |
| Reconciled Cost Of Revenue | 38.86 Cr | 34.65 Cr | 25.80 Cr | 28.91 Cr |
| EBITDA | 4.99 Cr | 5.47 Cr | 6.22 Cr | 2.25 Cr |
| EBIT | 4.54 Cr | 5.04 Cr | 5.85 Cr | 1.97 Cr |
| Net Interest Income | -0.80 Cr | -1.42 Cr | -1.98 Cr | -1.15 Cr |
| Interest Expense | 0.74 Cr | 1.32 Cr | 2.05 Cr | 1.23 Cr |
| Interest Income | 0.03 Cr | 0.00 | 0.10 Cr | 0.08 Cr |
| Normalized Income | 3.31 Cr | 2.81 Cr | 2.81 Cr | 0.54 Cr |
| Net Income From Continuing And Discontinued Operation | 3.31 Cr | 2.81 Cr | 2.81 Cr | 0.54 Cr |
| Total Expenses | 42.40 Cr | 39.34 Cr | 28.61 Cr | 30.89 Cr |
| Diluted NI Availto Com Stockholders | 3.31 Cr | 2.81 Cr | 2.81 Cr | 0.54 Cr |
| Net Income Common Stockholders | 3.31 Cr | 2.81 Cr | 2.81 Cr | 0.54 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 3.31 Cr | 2.81 Cr | 2.81 Cr | 0.54 Cr |
| Net Income Including Noncontrolling Interests | 3.31 Cr | 2.81 Cr | 2.81 Cr | 0.54 Cr |
| Net Income Continuous Operations | 3.31 Cr | 2.81 Cr | 2.81 Cr | 0.54 Cr |
| Tax Provision | 0.49 Cr | 0.91 Cr | 0.99 Cr | 0.20 Cr |
| Pretax Income | 3.80 Cr | 3.72 Cr | 3.80 Cr | 0.75 Cr |
| Other Non Operating Income Expenses | 0.45 Cr | 1.64 Cr | 0.75 Cr | 75000.00 |
| Special Income Charges | 0.00 | — | — | — |
| Net Non Operating Interest Income Expense | -0.80 Cr | -1.42 Cr | -1.98 Cr | -1.15 Cr |
| Total Other Finance Cost | 0.08 Cr | 0.10 Cr | 0.03 Cr | 64000.00 |
| Interest Expense Non Operating | 0.74 Cr | 1.32 Cr | 2.05 Cr | 1.23 Cr |
| Interest Income Non Operating | 0.03 Cr | 0.00 | 0.10 Cr | 0.08 Cr |
| Operating Income | 4.15 Cr | 3.49 Cr | 4.98 Cr | 1.89 Cr |
| Operating Expense | 3.54 Cr | 4.69 Cr | 2.81 Cr | 1.98 Cr |
| Other Operating Expenses | 0.83 Cr | 1.48 Cr | 0.82 Cr | 0.58 Cr |
| Depreciation And Amortization In Income Statement | 0.44 Cr | 0.43 Cr | 0.37 Cr | 0.28 Cr |
| Depreciation Income Statement | 0.44 Cr | 0.43 Cr | 0.37 Cr | 0.28 Cr |
| Selling General And Administration | 0.30 Cr | 0.95 Cr | 0.19 Cr | 0.14 Cr |
| General And Administrative Expense | 0.30 Cr | 0.13 Cr | 0.18 Cr | 0.13 Cr |
| Gross Profit | 7.69 Cr | 8.18 Cr | 7.79 Cr | 3.86 Cr |
| Cost Of Revenue | 38.86 Cr | 34.65 Cr | 25.80 Cr | 28.91 Cr |
| Total Revenue | 46.55 Cr | 42.83 Cr | 33.59 Cr | 32.77 Cr |
| Operating Revenue | 46.55 Cr | 42.83 Cr | 33.59 Cr | 32.77 Cr |
| Selling And Marketing Expense | — | 0.82 Cr | 0.01 Cr | 0.01 Cr |
| Diluted Average Shares | — | — | 3.30 Cr | 3.30 Cr |
| Basic Average Shares | — | — | 3.30 Cr | 3.30 Cr |
| Diluted EPS | — | — | 0.85 | 0.16 |
| Basic EPS | — | — | 0.85 | 0.16 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on JFL LIFE SCIENCES
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.